CCAAT/enhancer binding protein-α is down-regulated by toll-like receptor agonists in microglial cells

Journal of Neuroscience Research

Volumn 85, Issue 5, 2007, Pages 985-993

  Ejarque Ortiz, Aroa ^a   Tusell, Josep M ^a   Serratosa, Joan ^a   Saura, Josep ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Glial activation; In vitro; Lipopolysaccharide

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CCAAT ENHANCER BINDING PROTEIN ALPHA; COLONY STIMULATING FACTOR 1; CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; PEPTIDOGLYCAN; POLYINOSINIC POLYCYTIDYLIC ACID; TOLL LIKE RECEPTOR AFFECTING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL CULTURE; CONTROLLED STUDY; IN VITRO STUDY; INFLAMMATION; MICROGLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANIMALS, NEWBORN; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOKINES; DOWN-REGULATION; ENCEPHALITIS; GENE EXPRESSION REGULATION; GLIOSIS; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MICROGLIA; OLIGONUCLEOTIDES; PEPTIDOGLYCAN; POLY I-C; RNA, MESSENGER; TOLL-LIKE RECEPTORS;

EID: 34147211471     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.21195     Document Type: Article

References (41)

1. Alam T, An MR, Papaconstantinou J. 1992. Differential expression of three C/EBP isoforms in multiple tissues during the acute phase response. J Biol Chem 267:5021-5024.
2. An MR, Hsieh CC, Reisner PD, Rabek JP, Scott SG, Kuninger DT, Papaconstantinou J. 1996. Evidence for posttranscriptional regulation of C/EBPalpha and C/EBPbeta isoform expression during the lipopolysaccharide- mediated acute-phase response. Mol Cell Biol 16:2295-2306.
3. Birkenmeier EH, Gwynn B, Howard S, Jerry J, Gordon JI, Landschulz WH, McKnight SL. 1989. Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein. Genes Dev 3:1146-1156.
4. Blalock EM, Geddes JW, Chen KC, Porter NM, Markesbery WR, Landfield PW. 2004. Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci U S A 101:2173-2178.
5. Block ML, Hong JS. 2005. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 76:77-98.
6. Calkhoven CF, Muller C, Leutz A. 2000. Translational control of C/EBPalpha and C/EBPbeta isoform expression. Genes Dev 14:1920-1932.
7. Callejas NA, Bosca L, Williams CS, DuBois RN, Martin-Sanz P. 2000. Regulation of cyclooxygenase 2 expression in hepatocytes by CCAAT/enhancer- binding proteins. Gastroenterology 119:493-501.
8. Cassel TN, Nordlund-Moller L, Andersson O, Gustafsson JA, Nord M. 2000. C/EBPalpha and C/EBPdelta activate the clara cell secretory protein gene through interaction with two adjacent C/EBP-binding sites. Am J Respir Cell Mol Biol 22:469-480.
9. Chih DY, Park DJ, Gross M, Idos G, Vuong PT, Hirama T, Chumakov AM, Said J, Koeffler HP. 2004. Protein partners of C/EBPepsilon. Exp Hematol 32:1173-1181.
10. Cristiano L, Cimini A, Moreno S, Ragnelli AM, Paola CM. 2005. Peroxisome proliferator-activated receptors (PPARs) and related transcription factors in differentiating astrocyte cultures. Neuroscience 131:577-587.
11. Diehl AM, Yang SQ. 1994. Regenerative changes in C/EBP alpha and C/EBP beta expression modulate binding to the C/EBP site in the c-fos promoter. Hepatology 19:447-456.
12. Farina C, Theil D, Semlinger B, Hohlfeld R, Meinl E. 2004. Distinct responses of monocytes to Toll-like receptor ligands and inflammatory cytokines. Int Immunol 16:799-809.
13. Granger RL, Hughes TR, Ramji DP. 2000. Stimulus- and cell-type-specific regulation of CCAAT-enhancer binding protein isoforms in glomerular mesangial cells by lipopolysaccharide and cytokines. Biochim Biophys Acta 1501:171-179.
14. Hsieh CC, Xiong W, Xie Q, Rabek JP, Scott SG, An MR, Reisner PD, Kuninger DT, Papaconstantinou J. 1998. Effects of age on the posttranscriptional regulation of CCAAT/enhancer binding protein alpha and CCAAT/enhancer binding protein beta isoform synthesis in control and LPS-treated livers. Mol Biol Cell 9:1479-1494.
15. Jarvis BW, Qureshi N. 1997. Inhibition of lipopolysaccharide-induced transcription factor Sp1 binding by spectrally pure diphosphoryl lipid A from Rhodobacter sphaeroides, protein kinase inhibitor H-8, and dexamethasone. Infect Immun 65:1640-1643.
16. John GR, Lee SC, Brosnan CF. 2003. Cytokines: powerful regulators of glial cell activation. Neuroscientist 9:10-22.
17. Kariko K, Weissman D, Welsh FA. 2004. Inhibition of toll-like receptor and cytokine signaling - a unifying theme in ischemic tolerance. J Cereb Blood Flow Metab 24:1288-1304.
18. Kido J, Hayashi N, Kataoka M, Nagata T. 2005. Calprotectin expression in human monocytes: induction by porphyromonas gingivalis lipopolysaccharide, tumor necrosis factor-alpha, and interleukin-1beta. J Periodontal 76:437-442.
19. Kim SU, de Vellis J. 2005. Microglia in health and disease. J Neurosci Res 81:302-313.
20. Kolyada AY, Madias NE. 2001. Transcriptional regulation of the human iNOS gene by IL-1beta in endothelial cells. Mol Med 7:329-343.
21. Mackey SL, Darlington GJ. 2004. CCAAT enhancer-binding protein alpha is required for interleukin-6 receptor alpha signaling in newborn hepatocytes. J Biol Chem 279:16206-16213.
22. Milner R, Campbell IL. 2002. Cytokines regulate microglial adhesion to laminin and astrocyte extracellular matrix via protein kinase C-dependent activation of the alpha6beta1 integrin. J Neurosci 22:1562-1572.
23. Netea MG, van der GC, Van der Meer JW, Kullberg BJ. 2004. Toll-like receptors and the host defense against microbial pathogens: bringing specificity to the innate-immune system. J Leuk Biol 75:749-755.
24. Olson JK, Miller SD. 2004. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 173:3916-3924.
25. Pabst T, Mueller BU, Zhang P, Radomska HS, Narravula S, Schnittger S, Behre G, Hiddemann W, Tenen DG. 2001. Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia. Nat Genet 27:263-270.
26. Poli V. 1998. The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J Biol Chem 273:29279-29282.
27. Radomska HS, Huettner CS, Zhang P, Cheng T, Scadden DT, Tenen DG. 1998. CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol Cell Biol 18:4301-4314.
28. Saito H, Shultz LD, Sinha M, Papaconstantinou J. 1999. Induction of the alpha(1)-antichymotrypsin gene in the brain associated with TGF-beta1 deficiency or systemic administration of endotoxin. Biochem Biophys Res Commun 263:270-275.
29. Sakuta T, Matsushita K, Yamaguchi N, Oyama T, Motani R, Koga T, Nagaoka S, Abeyama K, Maruyama I, Takada H, Torii M. 2001. Enhanced production of vascular endothelial growth factor by human monocytic cells stimulated with endotoxin through transcription factor SP-1. J Med Microbiol 50:233-237.
30. Saura J, Tusell JM, Serratosa J. 2003. High-yield isolation of murine microglia by mild trypsinization. Glia 44:183-189.
31. Scott LM, Civin CI, Rorth P, Friedman AD. 1992. A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood 80:1725-1735.
32. Shuman JD, Cheong J, Coligan JE. 1997. ATF-2 and C/EBPalpha can form a heterodimeric DNA binding complex in vitro. Functional implications for transcriptional regulation. J Biol Chem 272:12793-12800.
33. Takeshita F, Suzuki K, Sasaki S, Ishii N, Klinman DM, Ishii KJ. 2004. Transcriptional regulation of the human TLR9 gene. J Immunol 173:2552-2561.
34. Tang QQ, Jiang MS, Lane MD. 1999. Repressive effect of Sp1 on the C/EBPalpha gene promoter: role in adipocyte differentiation. Mol Cell Biol 19:4855-4865.
35. Tengku-Muhammad TS, Hughes TR, Ranki H, Cryer A, Ramji DP. 2000. Differential regulation of macrophage CCAAT-enhancer binding protein isoforms by lipopolysaccharide and cytokines. Cytokine 12:1430-1436.
36. Walker DG, Link J, Lue LF, Dalsing-Hernandez JE, Boyes BE. 2006. Gene expression changes by amyloid beta peptide-stimulated human postmortem brain microglia identify activation of multiple inflammatory processes. J Leuk Biol 79:596-610.
37. Walton M, Saura J, Young D, MacGibbon G, Hansen W, Lawlor P, Sirimanne E, Gluckman P, Dragunow M. 1998. CCAAT-enhancer binding protein alpha is expressed in activated microglial cells after brain injury. Brain Res Mol Brain Res 61:11-22.
38. Wedel A, Sulski G, Ziegler-Heitbrock HW. 1996. CCAAT/enhancer binding protein is involved in the expression of the tumour necrosis factor gene in human monocytes. Cytokine 8:335-341.
39. Xie H, Ye M, Feng R, Graf T. 2004. Stepwise reprogramming of B cells into macrophages. Cell 117:663-676.
40. Yano S, Fukunaga K, Takiguchi M, Ushio Y, Mori M, Miyamoto E. 1996. Regulation of CCAAT/enhancer-binding protein family members by stimulation of glutamate receptors in cultured rat cortical astrocytes. J Biol Chem 271:23520-23527.
41. Zhang DE, Hetherington CJ, Meyers S, Rhoades KL, Larson CJ, Chen HM, Hiebert SW, Tenen DG. 1996. CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter. Mol Cell Biol 16:1231-1240.